Evidence map›Paper›PMID 27443615›Full record

ArticleThe Journal of infectious diseases2016

HLA-DRB1 Alleles Are Associated With Different Magnitudes of Dengue Virus-Specific CD4+ T-Cell Responses.

Daniela Weiskopf, Michael A Angelo, Alba Grifoni, Patrick H O'Rourke, John Sidney, Sinu Paul, Aruna D De Silva, Elizabeth Phillips, Simon Mallal, Sunil Premawansa and 4 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. T Cell Responses During Dengue Infection.Current topics in microbiology and immunology · 2026
    Review
  7. Human T Cell Responses to Flavivirus Vaccines.European journal of immunology · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Pathogenesis of Zika Virus Infection.Annual review of pathology · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Daniela WeiskopfDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, California.
Michael A AngeloDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, California.
Alba GrifoniDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, California.
Patrick H O'RourkeDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, California.
John SidneyDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, California.
Sinu PaulDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, California.
Aruna D De SilvaDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, California Genetech Research Institute.
Elizabeth PhillipsDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Australia.
Simon MallalDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee Institute for Immunology and Infectious Diseases, Murdoch University, Perth, Australia.
Sunil PremawansaDepartment of Zoology and Environmental Science, Science Faculty, University of Colombo.
Gayani PremawansaNorth Colombo Teaching Hospital, Ragama.
Ananda WijewickramaNational Institute of Infectious Diseases, Gothatuwa, Sri Lanka.
Bjoern PetersDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, California.
Alessandro SetteDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, California.

Funding

NIAID NIH HHS HHSN272200900042CNIAID NIH HHS HHSN272201400045C
6 · The paper itself

Abstract

backgroundEach year dengue virus (DENV) infects 400 million human but causes symptomatic disease in only a subset of patients, suggesting that host genetic factors may play a role. HLA molecules that restrict T-cell responses are one of the most polymorphic host factors in humans.

methodsHere we map HLA DRB1-restricted DENV-specific epitopes in individuals previously exposed to DENV, to identify the breadth and specificity of CD4(+) T-cell responses. To investigate whether HLA-specific variations in the magnitude of response might predict associations between dengue outcomes and HLA-DRB1 alleles, we assembled samples from hospitalized patients with known severity of disease.

resultsThe capsid protein followed by nonstructural protein 3 (NS3), NS2A, and NS5 were the most targeted proteins. We further noticed a wide variation in magnitude of T-cell responses as a function of the restricting DRB1 allele and found several HLA alleles that showed trends toward a lower risk of hospitalized disease were associated with a higher magnitude of T-cell responses.

conclusionsComprehensive identification of unique CD4(+) T-cell epitopes across the 4 DENV serotypes allows the testing of T-cell responses by use of a simple, approachable technique and points to important implications for vaccine design.

Indexed as

AdultCD4-Positive T-LymphocytesDengueDengue VirusEpitopes, T-LymphocyteHLA-DRB1 ChainsHumansEpitopes, T-LymphocyteHLA-DRB1 ChainsCD4+ T cellsDengue virusdisease associationHLA

Identifiers

PMID27443615
PMCPMC5021234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.